Santen Pharmaceutical Co Ltd

F:SZD

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SZD's stock price target?

Price Target

10.52 EUR

According to Wall Street analysts, the average 1-year price target for SZD is 10.52 EUR with a low forecast of 8.59 EUR and a high forecast of 13.17 EUR.

What is the Revenue forecast for Santen Pharmaceutical Co Ltd?

Projected CAGR

4%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 4%.

What is the Gross Profit forecast for Santen Pharmaceutical Co Ltd?

Projected CAGR

3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 2 years is 3%.

What is the Operating Income forecast for Santen Pharmaceutical Co Ltd?

Projected CAGR

29%

Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 1 year is 29%.

What is the Pre-Tax Income forecast for Santen Pharmaceutical Co Ltd?

Projected CAGR

6%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 2 years is 6%.

What is the Net Income forecast for Santen Pharmaceutical Co Ltd?

Projected CAGR

4%

Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 2 years is 4%.